This differentiation capacity is of the greatest interest for considering the clinical picture of MEN1 patients suffering from multiple gland parathyroid hyperplasia, along with non-functioning pancreatic neuroendocrine tumors [13]. This evidence concerns the gene MEN1 and pancreatic neuroendocrine tumor.